The Nasdaq listing could enhance SK Hynix's global visibility and liquidity, attracting US capital but exposing it to market cyclicality risks.
The post UBS advises investors to buy SK Hynix ADRs, sell Korean shares ahead of historic Nasdaq listing appeared first on Crypto Briefing.
The post Tether Pours $20 Million Into Mercado Bitcoin for Latin American Blockchain Growth appeared on BitcoinEthereumNews.com.
Oliver Dale Editor-in-Chief of Blockonomi and founder of Kooc Media, A UK-Based Online Media Company. Believer in Open-Source Software, Blockchain Technology & a Free and Fair Internet for all.
His writing has been quoted by Nasdaq, Dow Jones, Investopedia, The New Yorker, Forbes, Techcrunch & More. Contact Oliver@blockonomi.com Source: https://blockonomi.com/tether-pours-20-million-into-mercado-bitcoin-for-latin-american-blockchain-growth/
The post What SK Hynix’s Nasdaq debut and SpaceX’s Nasdaq 100 entry mean for investors appeared on BitcoinEthereumNews.com.
The Nasdaq is likely to take center stage for two of the market’’s most closely watched companies this week, although for very different reasons. South Korean memory chip giant SK Hynix is preparing to launch one of the largest American Depositary Receipt (ADR) offerings ever seen in the United States, while recently listed SpaceX is set to join the Nasdaq 100 just weeks after completing the largest IPO in history. Although these events are different, both represent important milestones that could significantly influence investor demand. In each case, Nasdaq is making the companies more accessible to global investors, expanding institutional and retail ownership and potentially attracting billions of dollars of passive capital. Yet history suggests that improved accessibility does not always translate into immediate share price gains. Could SK Hynix’s Nasdaq ADR L
The sharp decline in chip stocks signals a broader market reassessment, impacting global indices and crypto, highlighting risk asset volatility.
The post Nasdaq falls sharply as chip stocks decline, dragging Dow and crypto markets lower appeared first on Crypto Briefing.
The post Nasdaq arthritis company holding Moshe Hogeg crypto hits all-time low appeared on BitcoinEthereumNews.com.
As of 8:19am today in New York, every retail investor who had ever bought shares of Enlivex on the Nasdaq, an arthritis biotech-turned-digital asset treasury (DAT), had lost money. The company bet its balance sheet on the RAIN crypto token that ZachXBT eventually tied to Moshe Hogeg, an Israeli entrepreneur facing a $290 million law enforcement investigation. Shares of Enlivex, which have been trading publicly for 12 years, traded to their all-time low of $0.42 this morning. Investors are slowly losing it all. Hogeg has denied fraud allegations via a spokesperson. The biotech company spent years developing clinical therapeutics. Bizarrely, it then reinvented itself in November 2025 to what it called the “world’s first prediction markets digital asset treasury strategy.” That was a world first — and probably last. The company raised over $200 million through a private plac
The post Wall Street analyst sets QUBT stock price target for 12 months appeared on BitcoinEthereumNews.com.
As Quantum Computing Inc. (NASDAQ: QUBT) stock signals a macro reversal, Maxwell Michaelis, a Wall Street analyst at Lake Street, reiterated a bullish outlook on July 6. Michaelis maintained a Buy rating for QUBT stock, according to a note analyzed by Finbold on July 7, 2026. He also set a 12-month price target of $16 for Quantum Computing stock. The Wall Street analysts maintained a bullish outlook for Quantum Computing stock following its completed acquisition of NHanced Semiconductors. Notably, Quantum Computing acquired NHanced for a combined cash-and-share value of $73.1 million. The deal also includes an earnout of up to an additional $72.0 million. Michaelis framed the deal as a solid follow-up to the Luminar Semiconductor (LSI) acquisition, which closed in February. Moreover, the acquisitions could further deepen the company’s photonics manufacturing and advanced-packagi
The post Gemini (GEMI) Stock Drops 3.9% After Launching Commission-Free Stock Trading Platform appeared on BitcoinEthereumNews.com.
Key Takeaways Gemini rolled out commission-free U.S. stock trading Tuesday, providing access to thousands of exchange-listed equities through its mobile platform. Shares of GEMI declined 3.9% following the launch announcement; Coinbase (COIN) lost 2.4% and Robinhood (HOOD) slipped 2.3%. Real-time market data will be provided by Nasdaq; Apex Clearing Corp. serves as the clearing and custody partner. Alabama, Arkansas, Illinois, Massachusetts, Texas, Puerto Rico, Washington D.C., and Guam residents cannot access the new service. GEMI is currently priced at $4.35, representing an 86% decline year-over-year, despite recording 39% revenue growth over the trailing twelve months. Gemini Space Station unveiled its commission-free stock trading platform for U.S. investors on Tuesday, marking a strategic expansion beyond cryptocurrency as the Winklevoss brothers pur
SK Hynix's US listing success highlights strong investor confidence in AI infrastructure growth, potentially easing future memory shortages.
The post SK Hynix’s $28B US listing oversubscribed ahead of pricing, signaling massive appetite for AI chip plays appeared first on Crypto Briefing.
The post VRTX Elliott Wave forecast: Next bullish target at $556.9 – $646.4 appeared on BitcoinEthereumNews.com.
Vertex Pharmaceuticals Incorporated (VRTX), operates as Biotechnology company in the United States, Europe & internationally. It offers transformative medicines for people with serious diseases of different age groups. It comes under Healthcare – Biotech sector & trades as “VRTX” ticker at Nasdaq. In weekly, VRTX confirmed higher high above November-2024 high expected in last article. It should continue rally towards 556.9 – 591 area in shorter cycle within May-2026 sequence. We like to buy the pullback in 3, 7 or 11 swings at extreme area, when reach. VRTX – Elliott Wave latest weekly view In weekly, it placed ((I)) at $306.08 high (July-2020) & ((II)) at $176.36 low (October-2021). Above there, it ended (I) of ((III)) at $519.88 high (November-2024) & (II) at $362.50 low (August-2025). Within (I), it ended I at $292.75 high, II at $233.01 low, III at $510.63 high, IV at $4